Crimson Publishers Publish With Us Reprints e-Books Video articles

Abstract

Gastroenterology Medicine & Research

Minimal Hepatic Encephalopathy and Neuroinflammation

Submission: August 27, 2018; Published: October 25, 2018

DOI: 10.31031/GMR.2018.02.000533

ISSN 2637-7632
Volume2 Issue2

Abstract

Hepatic Encephalopathy (HE) is one of the major complications of acute or chronic liver failure. Its neurological and mental symptoms range from subtle behavioral abnormalities to deep coma and death. In addition, a subclinical HE state, named minimal HE (mHE) is a very frequent misdiagnosed complication. Although the etiology of hepatic encephalopathy is not fully elucidated, hyperammonemia plays a key role in its development. In liver diseases, its reduced detoxifying capability results in increased blood and brain ammonia concentrations. Under this condition, ammonia is neurotoxic to both neuronal and astrocyte cells in the CNS. Hyperammonemia is also an essential promotor of neuroinflammation increasing proinflammatory cytokines such as IL-1β and IL-6. It is known that even without morphological liver alterations, there are changes in the pro-inflammatory cytokines release and increase in the BBB permeability among other alterations. The aim of this review is to approach the neuroinflammatory aspects of minimal hepatic encephalopathy, where there are no clear manifestations of the disease.

Keywords: Minimal hepatic encephalopathy; Hyperammonemia; Neuroinflammation; Liver disease; Microglia; Astrocyte; AM404

Abbreviations: HE: Hepatic Encephalopathy; mHE: Minimal HE; CLF: Chronic Liver Failure; AASLD: American Association for the Study of Liver Diseases; EASL: European Association for the Study of the Liver; CNS: Central Nervous System; ROS: Reactive Oxygen Species; BBB: Blood-Brain Barrier; LPS: Lipopolysaccharide; GS: Glutamine Synthetase; MMP: Mitochondrial Membrane Potential; NO: Nitric Oxide; AQP: Aquaporins; NKCC1: Na-K-Cl Cotransporter-1

Get access to the full text of this article